Iteos Therapeutics Inc expected to post a loss of 89 cents a share - Earnings Preview

iTeos Therapeutics

06/11/2024 14:06

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected
to show a
rise in quarterly revenue when it reports  results on November 8
(estimated) for the period ending January 1 0001
    * The Watertown Massachusetts-based  company is expected to
report
revenue of $16.667 million, according to the mean estimate from
6 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Iteos Therapeutics Inc
is for
a loss of 89 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $33.50​, above​ its last closing price
of $9.22. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -1.04       -1.04      -0.18     Beat    82.7
 Mar. 31 2024  -0.97       -1.26      -1.07     Beat    14.8
 Jan. 1 0001   -0.93       -1.03      -0.85     Beat    17.7​
 Jan. 1 0001   -1.14       -1.20      -0.90     Beat    25.2
 ​​Jun.        -0.98       -1.03      -0.44     Beat    6.8
 30 2023                                                
 Mar. 31 2023  -1.00       -0.99      -0.44     Beat    55.8​
 Dec. 31 2022              0.33                         
 Sep. 30 2022  0.11        0.10       0.03      Missed  -69.2
 This summary was machine generated November 6 at 14:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)